121 related articles for article (PubMed ID: 33149212)
21. Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC.
Yang H; Liu Z; Wang Y; Li J; Li R; Wang Q; Hu C; Jiang H; Wu H; Song L; Bai Y
Ther Adv Med Oncol; 2020; 12():1758835920970845. PubMed ID: 33240400
[TBL] [Abstract][Full Text] [Related]
22. A model identifying characteristics predictive of successful pelvic floor muscle training outcomes among women with stress urinary incontinence.
Brooks KCL; Varette K; Harvey MA; Robert M; Brison RJ; Day A; Baker K; Della Zazzera V; Sauerbrei E; McLean L
Int Urogynecol J; 2021 Mar; 32(3):719-728. PubMed ID: 33237355
[TBL] [Abstract][Full Text] [Related]
23. Managing Nocturia in Frail Older Adults.
Wolff DT; Adler KA; Weinstein CS; Weiss JP
Drugs Aging; 2021 Feb; 38(2):95-109. PubMed ID: 33230803
[TBL] [Abstract][Full Text] [Related]
24. Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial.
Wages NA; Sanders JC; Smith A; Wood S; Anscher MS; Varhegyi N; Krupski TL; Harris TJ; Showalter TN
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1254-1262. PubMed ID: 33227441
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Uemura H; Matsushima H; Kobayashi K; Mizusawa H; Nishimatsu H; Fizazi K; Smith M; Shore N; Tammela T; Tabata KI; Matsubara N; Iinuma M; Uemura H; Oya M; Momma T; Kawakita M; Fukasawa S; Kobayashi T; Kuss I; Le Berre MA; Snapir A; Sarapohja T; Suzuki K
Int J Clin Oncol; 2021 Mar; 26(3):578-590. PubMed ID: 33226524
[TBL] [Abstract][Full Text] [Related]
26. Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
Huang B; Huang G; Li W; Chen L; Mao X; Chen J
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1781-1788. PubMed ID: 33222014
[TBL] [Abstract][Full Text] [Related]
27. Management of prostate cancer after holmium laser enucleation of the prostate.
Hutchison D; Peabody H; Kuperus JM; Humphrey JE; Ryan M; Moriarity A; Brede CM; Lane BR
Urol Oncol; 2021 May; 39(5):297.e1-297.e8. PubMed ID: 33221258
[TBL] [Abstract][Full Text] [Related]
28. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.
Lin L; Kane N; Kobayashi N; Kono EA; Yamashiro JM; Nickols NG; Reiter RE
Clin Cancer Res; 2021 Mar; 27(5):1505-1515. PubMed ID: 33219015
[TBL] [Abstract][Full Text] [Related]
29. Treatment Options in Oligometastatic Disease in Prostate Cancer: Thinking Outside the Box.
Fleming CW; Broughman JR; Tendulkar RD
Curr Treat Options Oncol; 2020 Nov; 22(1):2. PubMed ID: 33216272
[TBL] [Abstract][Full Text] [Related]
30. Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer.
Telkhade T; Murthy V; Kanala TS; Mathew JM; Phurailatpam R; Mokal S; Chourasiya D; Panigrahi G; Krishnatry R
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):172-180. PubMed ID: 33214044
[TBL] [Abstract][Full Text] [Related]
31. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis.
Qiu D; Hu J; He T; Li H; Hu J; Yi Z; Chen J; Zu X
Transl Androl Urol; 2020 Oct; 9(5):2094-2106. PubMed ID: 33209672
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
Bowden M; Nadal R; Zhou CW; Werner L; Barletta J; Juanpere N; Lloreta J; Hernandez-Llodrà S; Morote J; de Torres I; Orsola A; Cejas P; Long H; Bellmunt J
Sci Rep; 2020 Nov; 10(1):20135. PubMed ID: 33208770
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study.
Procopio G; Chiuri VE; Giordano M; Mantini G; Maisano R; Bordonaro R; Calvani N; Facchini G; De Placido S; Airoldi M; Sbrana A; Gasparro D; Ludovico GM; Guglielmini P; Naglieri E; Fagnani D; Aglietta M; Schips L; Beccaglia P; Sciarra A; Livi L; Santini D
Ther Adv Med Oncol; 2020; 12():1758835920968725. PubMed ID: 33193831
[TBL] [Abstract][Full Text] [Related]
34. Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
Guerrios-Rivera L; Howard LE; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Freedland SJ
Urology; 2021 Mar; 149():181-186. PubMed ID: 33189734
[TBL] [Abstract][Full Text] [Related]
35. External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA.
Stolzenbach LF; Rosiello G; Deuker M; Martin T; Knipper S; Tian Z; Briganti A; Zorn KC; Saad F; Chun FKH; Graefen M; Karakiewicz PI
Urol Oncol; 2021 Feb; 39(2):131.e1-131.e7. PubMed ID: 33189532
[TBL] [Abstract][Full Text] [Related]
36. Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
Fischer-Valuck BW; Michalski JM; Harton JG; Birtle A; Christodouleas JP; Efstathiou JA; Arora VK; Kim EH; Knoche EM; Pachynski RK; Picus J; Rao YJ; Reimers M; Roth BJ; Sargos P; Smith ZL; Zaghloul MS; Gay HA; Patel SA; Baumann BC
Clin Genitourin Cancer; 2021 Feb; 19(1):41-46.e1. PubMed ID: 33187904
[TBL] [Abstract][Full Text] [Related]
37. Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival.
Volz Y; Grimm T; Ormanns S; Eismann L; Pfitzinger PL; Jokisch JF; Schulz G; Casuscelli J; Schlenker B; Karl A; Stief CG; Kretschmer A
Urol Oncol; 2021 May; 39(5):299.e15-299.e21. PubMed ID: 33187885
[TBL] [Abstract][Full Text] [Related]
38. Fusion US/MRI prostate biopsy using a computer aided diagnostic (CAD) system.
Ferriero M; Anceschi U; Bove AM; Bertini L; Flammia RS; Zeccolini G; DE Concilio B; Tuderti G; Mastroianni R; Misuraca L; Brassetti A; Guaglianone S; Gallucci M; Celia A; Simone G
Minerva Urol Nephrol; 2021 Oct; 73(5):616-624. PubMed ID: 33179868
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
Sun Y; Li SH; Cheng JW; Chen G; Huang ZG; Gu YY; Yan HB; He ML
Biomed Res Int; 2020; 2020():6037434. PubMed ID: 33178832
[TBL] [Abstract][Full Text] [Related]
40. Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship.
Marzouka NA; Lindgren D; Eriksson P; Sjödahl G; Bernardo C; Liedberg F; Axelson H; Höglund M
Sci Rep; 2020 Nov; 10(1):19539. PubMed ID: 33177554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
